Invesco Ltd. Repligen Corp Call Options Transaction History
Invesco Ltd.
- $460 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RGEN
# of Institutions
497Shares Held
53.9MCall Options Held
423KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.09 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$729 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$663 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$250 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$205 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.98B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....